Evaluation of Specific IgG Antibody in Subjects Who Had Been Previously Infected with SARS-CoV-2.
作者信息
Rostami Soodabeh, Ahangarzadeh Shahrzad, Zamani Moghaddam Ali, Nokhodian Zary, Modaresifar Hossein, Roustaei Amirsaman, Shoaei Parisa, Rowzati Mohsen, Tahvilian Zohreh, Nazari Alireza, Kassaian Nazila, Haghjooy Javanmard Shaghayegh, Ataei Behrooz
机构信息
Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Ira, Iran.
Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
出版信息
Adv Biomed Res. 2023 Jun 30;12:171. doi: 10.4103/abr.abr_195_22. eCollection 2023.
Abstract
摘要
相似文献
1
Evaluation of Specific IgG Antibody in Subjects Who Had Been Previously Infected with SARS-CoV-2.对曾感染过新冠病毒的受试者体内特异性IgG抗体的评估。
Adv Biomed Res. 2023 Jun 30;12:171. doi: 10.4103/abr.abr_195_22. eCollection 2023.
2
Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?mRNA SARS-CoV-2 疫苗接种后抗刺突抗体的持久性在既往感染者中更长：是否可以延迟加强针接种？
Infection. 2022 Dec;50(6):1573-1577. doi: 10.1007/s15010-022-01816-9. Epub 2022 Apr 7.
3
Clinical Evaluation of Serum Levels of SARS-CoV-2 Anti-Spike Protein IgG Antibodies in Infected Patients and Vaccinated Subjects.感染患者和接种疫苗者血清中 SARS-CoV-2 抗刺突蛋白 IgG 抗体水平的临床评估
Clin Lab. 2022 Jul 1;68(7). doi: 10.7754/Clin.Lab.2021.211101.
4
Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2.接种BNT162b2疫苗15周后，初次感染和既往感染受试者的抗体反应衰减及对VOC敏感性的差异
J Transl Med. 2022 Jan 8;20(1):22. doi: 10.1186/s12967-021-03208-3.
5
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.COVID-19 恢复期患者体内 SARS-CoV-2 抗体动态变化和 B 细胞记忆应答特征。
Clin Microbiol Infect. 2021 Sep;27(9):1349.e1-1349.e6. doi: 10.1016/j.cmi.2021.05.008. Epub 2021 May 8.
6
Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.感染 SARS-CoV-2 后和接种 COVID-19 疫苗后针对 SARS-CoV-2 刺突蛋白的唾液和血清 IgA 和 IgG 反应。
Allergy Asthma Proc. 2022 Sep 1;43(5):419-430. doi: 10.2500/aap.2022.43.220045.
7
Antibody responses to the BBV152 vaccine in individuals previously infected with SARS-CoV-2: A pilot study.先前感染过 SARS-CoV-2 的个体对 BBV152 疫苗的抗体反应：一项初步研究。
Indian J Med Res. 2021 May;153(5&6):671-676. doi: 10.4103/ijmr.IJMR_2066_21.
8
Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine.人类针对灭活的 SARS-CoV-2 疫苗的 IgM 和 IgG 反应。
Curr Med Sci. 2021 Dec;41(6):1081-1086. doi: 10.1007/s11596-021-2461-8. Epub 2021 Nov 6.
9
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study.在以色列家庭中暴露于 SARS-CoV-2 的接种个体中 COVID-19 感染和症状性疾病严重程度的保护相关性（ICoFS）：一项前瞻性队列研究。
Lancet Microbe. 2023 May;4(5):e309-e318. doi: 10.1016/S2666-5247(23)00012-5. Epub 2023 Mar 21.
10
Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2.血清 IgG 抗 SARS-CoV-2 结合抗体水平与成人感染 SARS-CoV-2 时的 IgA 和功能性抗体水平密切相关。
Front Immunol. 2021 Oct 8;12:693462. doi: 10.3389/fimmu.2021.693462. eCollection 2021.
本文引用的文献
1
The Effect of Smoking on Humoral Response to COVID-19 Vaccines: A Systematic Review of Epidemiological Studies.吸烟对新冠疫苗体液免疫反应的影响：流行病学研究的系统评价
Vaccines (Basel). 2022 Feb 16;10(2):303. doi: 10.3390/vaccines10020303.
2
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.从 COVID-19 阳性受试者中分离和鉴定交叉中和冠状病毒抗体。
Cell Rep. 2021 Jul 13;36(2):109353. doi: 10.1016/j.celrep.2021.109353. Epub 2021 Jun 22.
3
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment.SARS-CoV-2 抗体的综合概述及其在 COVID-19 预防和治疗中的可能应用。
Microb Cell Fact. 2021 Apr 22;20(1):88. doi: 10.1186/s12934-021-01576-5.
4
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.来自 COVID-19 患者的强效中和抗体定义了多个易损目标。
Science. 2020 Aug 7;369(6504):643-650. doi: 10.1126/science.abc5902. Epub 2020 Jun 15.
5
Serum IgA, IgM, and IgG responses in COVID-19.新冠病毒肺炎中的血清IgA、IgM和IgG反应。
Cell Mol Immunol. 2020 Jul;17(7):773-775. doi: 10.1038/s41423-020-0474-z. Epub 2020 May 28.
6
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
7
Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.新型冠状病毒感染诊断用快速 IgM-IgG 联合抗体检测试剂的研制与临床应用
J Med Virol. 2020 Sep;92(9):1518-1524. doi: 10.1002/jmv.25727. Epub 2020 Apr 13.
Zotero 插件